Security key
83086J101
- Security type / class
- Equity / CS
- Total 13F shares
- 11,900
- Total 13F value
- $193
- Share change
- +11,900
- SEC-reported price per share
- $0.02
- Number of holders
- 1
- Value change
- +$193
- Number of buys
- 1
Report period
Q4 2022
Institutions
1
Top holders
1
SKYE full security history
Ownership snapshot
Full 13F holder table
Skye Bioscience, Inc. SEC filings
Skye Bioscience, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SKYE - Skye Bioscience Inc - CS (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Emerald Health Sciences Inc.
Disclosed value leader
Emerald Health Sciences Inc.
Comparable rows
0/2
Latest evidence
10 Nov 2022
3/4/5
Highest disclosed value: $3,167,928
2 rows are not safely comparable across share classes.
Quick read
Emerald Health Sciences Inc. has the largest disclosed position value at $3.17M.
0 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Emerald Health Sciences Inc.'s linked filing trail.
Disclosed position value
Top 1
Emerald Health Sciences Inc.
$3.17M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-2 of 2 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Emerald Health Sciences Inc. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$3,167,928
169,407,901 shares
|
— | 10 Nov 2022 |
| James L. Heppell |
3/4/5
Director
|
—
denominator unverified
|
—
1,350,000 shares
|
— | 14 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
11,900
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
0
Q4 2022 holders
1
Holder diff
1
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|